JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
iShares MSCI China A ETF
CNYA
$208M
| $11.6M | ﹤0.01% |
304,129
-3,444,934
| -92% | -$120M |
|
|
XM
1952
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $11.6M | ﹤0.01% |
924,995
+825,739
| +832% | +$14.7M |
|
1953
Element Solutions
ESI
$9.37B
| $11.6M | ﹤0.01% |
649,041
+360,057
| +125% | +$7.31M |
|
1954
Ascendis Pharma A/S
ASND
$16.8B
| $11.5M | ﹤0.01% |
124,211
+105,402
| +560% | +$9.93M |
|
1955
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
| $11.5M | ﹤0.01% |
311,402
+165,883
| +114% | +$6.75M |
|
1956
CALL
Canadian Solar
CSIQ
$1.07B
| $11.5M | ﹤0.01% |
370,000
| – | – |
|
|
ITOS
1957
DELISTED
iTeos Therapeutics
ITOS
| $11.5M | ﹤0.01% |
559,299
+332,625
| +147% | +$7.89M |
|
1958
FLEX LNG
FLNG
$1.6B
| $11.5M | ﹤0.01% |
420,075
+153,734
| +58% | +$4.3M |
|
1959
Flowserve
FLS
$10.3B
| $11.5M | ﹤0.01% |
401,832
-445,959
| -53% | -$14.2M |
|
|
FLG
1960
Flagstar Bank National Association
FLG
$5.9B
| $11.5M | ﹤0.01% |
419,713
+59,239
| +16% | +$1.7M |
|
1961
Schrodinger
SDGR
$1.39B
| $11.5M | ﹤0.01% |
435,064
+133,277
| +44% | +$3.58M |
|
1962
argenx
ARGX
$54.8B
| $11.5M | ﹤0.01% |
30,256
+28,679
| +1,819% | +$9.24M |
|
1963
Rambus
RMBS
$11B
| $11.4M | ﹤0.01% |
532,628
-73,232
| -12% | -$1.81M |
|
1964
Carvana
CVNA
$79.7B
| $11.4M | ﹤0.01% |
2,532,655
+685,655
| +37% | +$7.21M |
|
1965
Syndax Pharmaceuticals
SNDX
$1.77B
| $11.4M | ﹤0.01% |
594,302
+354,473
| +148% | +$5.9M |
|
1966
Interparfums
IPAR
$3.78B
| $11.4M | ﹤0.01% |
155,602
+41,239
| +36% | +$3.16M |
|
1967
Westamerica Bancorp
WABC
$1.38B
| $11.3M | ﹤0.01% |
203,369
-2,672
| -1% | -$157K |
|
1968
VanEck Biotech ETF
BBH
$429M
| $11.3M | ﹤0.01% |
+77,431
| New | +$11.5M |
|
1969
Primoris Services
PRIM
$4.39B
| $11.3M | ﹤0.01% |
518,664
+18,631
| +4% | +$449K |
|
1970
National Healthcare
NHC
$3.47B
| $11.3M | ﹤0.01% |
161,094
-470
| -0.3% | -$32.9K |
|
1971
ATI
ATI
$31.4B
| $11.3M | ﹤0.01% |
495,569
+90,358
| +22% | +$2.38M |
|
1972
Enterprise Financial Services Corp
EFSC
$2.41B
| $11.2M | ﹤0.01% |
270,770
-5,715
| -2% | -$255K |
|
1973
Curtiss-Wright
CW
$26.7B
| $11.2M | ﹤0.01% |
85,010
+957
| +1% | +$136K |
|
1974
Rollins
ROL
$17.6B
| $11.2M | ﹤0.01% |
320,984
+92,781
| +41% | +$3.19M |
|
1975
Teradata
TDC
$2.49B
| $11.2M | ﹤0.01% |
302,812
+33,305
| +12% | +$1.33M |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.